Kane Biotech Investor Relations Material
Latest events
Investor Update
Kane Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Kane Biotech Inc
Access all reports
Kane Biotech Inc. is a biotechnology company engaged in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. Biofilms are complex communities of bacteria that can adhere to surfaces and are resistant to antibiotics and chemical agents. Kane Biotech's portfolio includes solutions for human health, animal health, and industrial applications, focusing on addressing challenges related to biofilm-related infections and contamination. The company is headquartered in Winnipeg, Canada, and its shares are listed on the TSX.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
KNE
Country
🇨🇦 Canada